Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Clinical Trials

US FDA Accepts for Review a BLA for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine

(BUSINESS WIRE) October 20, 2014 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT:SAN and NYSE:SNY), announced today that the Biologics License Application (BLA) filed for the companies’ investigational pediatric hexavalent vaccine, DTaP5-IPV-Hib-HepB1, has been accepted...

Posted today in Clinical Trials

CytRx Announces Publication of Phase 1b/2 Aldoxorubicin Clinical Data

CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that a paper, titled "A Phase 1b/2 Study of Aldoxorubicin in Patients With Soft Tissue Sarcoma," has been published online in Cancer, the prestigious, peer-reviewed journal of the American Cancer Society. The paper discusses results...

Posted 3 days ago in New Drug Approvals

FDA Approves Labeling with Abuse-Deterrent Features for Embeda (morphine/naltrexone)

The U.S. Food and Drug Administration today approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release (ER) capsules, an opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Embeda is the third ER...

Posted today in Medical

Some Lung Patients Buy Cigarettes Along With Meds at Pharmacies: Study

While picking up a prescription for cholesterol-lowering medication, about one in 20 people with conditions such as asthma, chronic obstructive pulmonary disease (COPD) or high blood pressure will also purchase cigarettes, a new study finds. Six percent of people with asthma or COPD, and about 5 percent of people with high blood pressure or those picking...

Posted today in Medical

Regular Doctor Visits Help Control Blood Pressure, Study Says

Regular visits to your doctor can help keep your blood pressure under control, a new study shows. High blood pressure can cause serious health problems such as stroke and heart attack, according to the American Heart Association. Researchers analyzed data from 37,000 American adults who had their blood pressure checked between 1999 and 2012. Those...

Posted today in Medical

Pricey Hepatitis Drug a Good Bet in U.S. Prisons, Study Says

Using an expensive drug to treat prison inmates with hepatitis C is more cost-effective than another treatment option, according to a new study. More than 500,000 prison inmates in the United States have hepatitis C, which causes liver damage. It's spread by contact with infected blood. The drug Sovaldi (sofosbuvir) costs more than $7,000 a week for...

Posted today in Medical

Parkinson's Drugs May Spur Compulsive Behaviors

Drugs commonly used to treat Parkinson's disease may raise the risk of so-called impulse control disorders, according to a new review. These disorders include compulsive gambling, compulsive shopping and/or hypersexuality. That increased risk was seen in a fresh review of a decade's worth of U.S. Food and Drug Administration (FDA) records. "What...

Posted today in Medical

Herceptin Boosts Survival for Breast Cancer, Study Reports

Adding the drug Herceptin to chemotherapy for certain breast cancer patients increases overall survival and reduces the risk of recurrence compared to chemotherapy alone, new research shows. The study found that adding a year of Herceptin (trastuzumab) to standard chemotherapy improved overall survival by 37 percent. The addition of Herceptin also...

Posted today in Medical

Mouse Study Suggests Antibiotics May Aid Salmonella's Spread in Animals

Antibiotics might actually help Salmonella -- bacteria that cause food poisoning -- spread among infected animals, according to new research. Although this phenomenon isn't yet known to have occurred among people, the study's authors cautioned their findings should serve as a reminder of the potential dangers of antibiotic use. They also noted that...

Posted today in Medical

CDC Tightens Rules on Caring for Ebola Patients

U.S. health officials on Monday officially tightened guidelines for health workers treating Ebola patients, now requiring full body suits with no skin exposure and use of a respirator at all times. The U.S. Centers for Disease Control and Prevention decided to issue the tougher rules after two Dallas nurses contracted Ebola while caring for the first...

Read more news...

Recently added consumer and prescribing information: Vitekta, Harvoni, Trulicity, Movantik, Contrave, Keytruda, Kabiven, Triumeq, Arnuity Ellipta, Cerdelga

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

Posted in Blog

Fox News Features Drugs.com Medication Guide app

Thanks to Fox News for showcasing the Drugs.com Medication Guide app today. Very much appreciated. Available in both the Apple App store and the Google Play store, this is a great app for ultra-quick research and/or keeping track of multiple meds. Check out the video at the link below… http://www.foxnews.com/health/2014/07/13/drugscom-app-provides-medical-information-on-go/ And check out the apps here… http://www.drugs.com/apps/

Posted in Blog

Heartbleed Update

Drugs.com utilizes the Akamai content delivery network to serve our website to end users. Akamai patched the announced Heartbleed vulnerability prior to its public announcement. Akamai, like all users of OpenSSL, could have exposed passwords or session cookies transiting our network from August 2012 through 4 April 2014. Their custom memory allocator protected against nearly […]

See more blog posts or follow us on twitter.

Return to top

You are viewing the mobile version of Drugs.com. If required, you can switch to the desktop version.

Copyright © 2000-2014 Drugs.com. All rights reserved. Terms of Use · Privacy Policy